Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00047970 · ClinicalTrials.gov registry record

The Sister Study: Genetic and Environmental Risk Factors for Breast Cancer

A clinical trial, sponsored by National Institute of Environmental Health Sciences (NIEHS).

Completed
Registry status
50,884
Enrollment target

NCT00047970: Completed study, sponsored by National Institute of Environmental Health Sciences (NIEHS).

NCT00047970 is a clinical trial that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 50,884 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00047970 has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).

COMPLETED
Registry status
50,884 participants
Enrollment target

Study Summary

The Sister Study is prospectively examining environmental and familial risk factors for breast cancer and other diseases in a cohort of 50,884 sisters of women who have had breast cancer. Such sisters have about twice the risk of developing breast cancer as other women.

Trial Details

FieldValue
Enrollment Target 50,884 participants
Start Date 2003-08
Est. Completion 2015-04

What the finished NCT00047970 record still lists

NCT00047970 is an observational study that tracks outcomes without assigning an intervention. Its 50,884 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT00047970 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00047970 about?

NCT00047970 is a clinical study titled "The Sister Study: Genetic and Environmental Risk Factors for Breast Cancer". The Sister Study is prospectively examining environmental and familial risk factors for breast cancer and other diseases in a cohort of 50,884 sisters of women who have had breast cancer. Such sisters have about twice the risk of developing breast cancer as other women.

What is the current status of trial NCT00047970?

This trial is currently completed. The enrollment target is 50,884 participants. The study started on 2003-08. Estimated completion is 2015-04.

Who is sponsoring clinical trial NCT00047970?

This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00500123 · 50,000 participants

    The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

  • NCT01885299 · 50,000 participants

    RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

  • NCT03452774 · 50,000 participants

    SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • NCT04629586 · 50,000 participants

    The T1D Exchange Registry

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00047970, the US trial registry maintained by the National Library of Medicine. NCT00047970 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.